ESMO 2022 | The urgent need for adjuvant therapies in glioblastoma

Nader Sanai, MD, Barrow Neurological Institute, Phoenix, AZ, discusses the unmet need of adjuvant therapies in glioblastoma to complement the progress that has been made in the field of surgery and radiotherapy for this patent population. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.